Literature DB >> 17006675

Interindividual variability of aminoglycoside pharmacokinetics in preterm neonates at birth.

Karel Allegaert, Brian J Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006675     DOI: 10.1007/s00228-006-0204-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Limited predictability of amikacin clearance in extreme premature neonates at birth.

Authors:  Karel Allegaert; Brian J Anderson; Veerle Cossey; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example.

Authors:  R E Ferner; N J Langford; C Anton; A Hutchings; D N Bateman; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

3.  Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants.

Authors:  Karel Allegaert; Anne Debeer; Veerle Cossey; Maissa Rayyan; Hugo Devlieger
Journal:  Pediatr Crit Care Med       Date:  2006-03       Impact factor: 3.624

4.  Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.

Authors:  Jens Rengelshausen; Bernd Beedgen; Konstantina Tsamouranis; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli; Otwin Linderkamp
Journal:  Eur J Clin Pharmacol       Date:  2006-07-25       Impact factor: 2.953

5.  Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.

Authors:  J P Langhendries; O Battisti; J M Bertrand; A François; M Kalenga; J Darimont; E Scalais; P Wallemacq
Journal:  Biol Neonate       Date:  1998-11
  5 in total
  3 in total

1.  CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.

Authors:  Robert Gross; Scarlett L Bellamy; Bakgaki Ratshaa; Xiaoyan Han; Marijana Vujkovic; Richard Aplenc; Andrew P Steenhoff; Mosepele Mosepele; Ganesh Moorthy; Athena F Zuppa; Brian L Strom; Gregory P Bisson
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 2.  Therapeutic drug monitoring of aminoglycosides in neonates.

Authors:  Daniël J Touw; Elsbeth M Westerman; Arwen J Sprij
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

3.  Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?

Authors:  John N van den Anker; Karel Allegaert
Journal:  Eur J Clin Pharmacol       Date:  2009-07-07       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.